EverGlade Consulting Blog
- EverGlade Consulting Funding Alert: Biden Administration Announces Launch of Successor Program to Operation Warp Speed Accompanied by the Release of New Funding Opportunities for the Development of Vaccines and Therapeutics Project Next Gen Project
- DTRA Funding Alert: Amendment to DTRA Chemical / Biological Technologies Broad Agency Announcement Includes Additional Funding Opportunities to Develop Bioinformatics Capabilities, Ocular Sampling Technologies, and MCMs for Chemical Warfare Agents On March 21, 2023,
- New Funding Opportunities Available Through the New Advanced Research Projects Agency for Health (ARPA-H) BAA ARPA-H, or the Advanced Research Projects Agency for Health, is an agency within the National Institutes of Health (NIH)
- Amendment to BAA Outlines New DTRA Funding Opportunities to Develop Novel Technologies and Medical Countermeasures Against Weapons of Mass Destruction (WMD) and Emerging Threats The Defense Threat Reduction Agency (DTRA) recently published an amendment
- The National Institute of Allergy and Infectious Diseases (“NIAID”) recently published Broad Agency Announcement (‘BAA”) No. HHS-NIH-NIAID-BAA2023-1, which provides funding opportunities for the advancement of promising candidate vaccines, therapeutics, and diagnostics for Biodefense, Emerging
- New Strategy Leads to New Funding Opportunities for the Development of Medical Countermeasures In the wake of the Coronavirus Disease 2019 (COVID-19) pandemic and a rapidly expanding landscape of biological and chemical threats, the